A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

China's number of new drug approvals last year reached a record high, with overseas technology export revenue exceeding 188 trillion Korean won. During the same period, the United States saw a ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...

“There are over 600,000 drugs in the Korea Chemical Bank alone. It felt overwhelming to find a drug that perfectly fits the protein structure we’re targeting among them. That’s when I thought of AI ...

Real-World Data and Real-World Evidence (RWD/RWE) have been utilized not only for drug safety assessment but also for ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory processes and reduction of drug approval timelines to facilitate and speed up the ...

Cambridge’s Kendall Square bills itself as “the most innovative square mile on the planet” — but it’s possible that less of that innovation is happening in Cambridge as life science firms outsource ...

Two formative experiences shaped Craig Crews’ path into drug development. First, when he was still a child, his grandmother died from cancer at just 52 years old. “At the time, there weren’t very many ...